Vocal Tremor Reduction withDeep Brain Stimulation

1999 ◽  
Vol 72 (2-4) ◽  
pp. 241-244 ◽  
Author(s):  
Michael S. Yoon ◽  
Michael Munz ◽  
Robert T. Sataloff ◽  
Joseph R. Spiegel ◽  
Reinhardt J. Heuer
Cureus ◽  
2015 ◽  
Author(s):  
Allen L Ho ◽  
Omar Choudhri ◽  
C. Kwang Sung ◽  
Elizabeth E DiRenzo ◽  
Casey H Halpern

2015 ◽  
Vol 38 (6) ◽  
pp. E6 ◽  
Author(s):  
Allen L. Ho ◽  
Elizabeth Erickson-Direnzo ◽  
Arjun V. Pendharkar ◽  
Chih-Kwang Sung ◽  
Casey H. Halpern

Tremulous voice is a characteristic feature of a multitude of movement disorders, but when it occurs in individuals diagnosed with essential tremor, it is referred to as essential vocal tremor (EVT). For individuals with EVT, their tremulous voice is associated with significant social embarrassment and in severe cases may result in the discontinuation of employment and hobbies. Management of EVT is extremely difficult, and current behavioral and medical interventions for vocal tremor result in suboptimal outcomes. Deep brain stimulation (DBS) has been proposed as a potential therapeutic avenue for EVT, but few studies can be identified that have systematically examined improvements in EVT following DBS. The authors describe a case of awake bilateral DBS targeting the ventral intermediate nucleus for a patient suffering from severe voice and arm tremor. They also present their comprehensive, multidisciplinary methodology for definitive treatment of EVT via DBS. To the authors’ knowledge, this is the first time comprehensive intraoperative voice evaluation has been used to guide microelectrode/stimulator placement, as well as the first time that standard pre- and post-DBS assessments have been conducted, demonstrating the efficacy of this tailored DBS approach.


2020 ◽  
Vol 29 (2) ◽  
pp. 851-863
Author(s):  
Elizabeth Erickson-DiRenzo ◽  
C. Kwang Sung ◽  
Allen L. Ho ◽  
Casey H. Halpern

Purpose Essential vocal tremor (EVT) is a prevalent and difficult-to-manage voice disorder. There is evidence that deep brain stimulation (DBS) of the ventral intermediate nucleus (Vim) of the thalamus may be beneficial for treating EVT. The objective of this preliminary investigation was to conduct intraoperative voice assessments during Vim-DBS implantation in order to evaluate immediate voice outcomes in medication-refractory essential tremor patients with co-occurring EVT. Method Seven adult subjects diagnosed with EVT undergoing Vim-DBS surgery participated in this investigation. Voice samples of sustained vowels were collected by a speech-language pathologist preoperatively and intraoperatively, immediately following Vim-DBS electrode placement. Voice evaluation included objective acoustic assessment of the rate and extent of EVT fundamental frequency and intensity modulation and subjective perceptual ratings of EVT severity. Results The rate of intensity modulation, extent of fundamental frequency modulation, and perceptual rating of EVT severity were significantly reduced intraoperatively as compared to preoperatively. Moderate, positive correlations were appreciated between a subset of acoustic measures and perceptual severity ratings. Conclusions The results of this study demonstrate a speech-language pathologist can conduct intra-operative evaluation of EVT during DBS surgery. Using a noninvasive, simple acoustic recording method, we were able to supplement perceptual subjective observation with objective assessment and demonstrate immediate, intraoperative improvements in EVT. The findings of this analysis inform the added value of intraoperative voice evaluation in Vim-DBS patients and contribute to the growing body of literature seeking to evaluate the efficacy of DBS as a treatment for EVT.


2016 ◽  
Vol 6 (4) ◽  
pp. 48 ◽  
Author(s):  
Vinod Ravikumar ◽  
Allen Ho ◽  
Jonathon Parker ◽  
Elizabeth Erickson-DiRenzo ◽  
Casey Halpern

2020 ◽  
Vol 81 ◽  
pp. 106-112
Author(s):  
Elizabeth Erickson-DiRenzo ◽  
Fiene Marie Kuijper ◽  
Daniel A.N. Barbosa ◽  
Erika A. Lim ◽  
Peter T. Lin ◽  
...  

2002 ◽  
Vol 16 (1) ◽  
pp. 132-135 ◽  
Author(s):  
Robert Thayer Sataloff ◽  
Reinhardt J Heuer ◽  
Michael Munz ◽  
Michael S Yoon ◽  
Joseph R Spiegel

2018 ◽  
Vol 75 (7) ◽  
pp. 448-454
Author(s):  
Thomas Grunwald ◽  
Judith Kröll

Zusammenfassung. Wenn mit den ersten beiden anfallspräventiven Medikamenten keine Anfallsfreiheit erzielt werden konnte, so ist die Wahrscheinlichkeit, dies mit anderen Medikamenten zu erreichen, nur noch ca. 10 %. Es sollte dann geprüft werden, warum eine Pharmakoresistenz besteht und ob ein epilepsiechirurgischer Eingriff zur Anfallsfreiheit führen kann. Ist eine solche Operation nicht möglich, so können palliative Verfahren wie die Vagus-Nerv-Stimulation (VNS) und die tiefe Hirnstimulation (Deep Brain Stimulation) in eine bessere Anfallskontrolle ermöglichen. Insbesondere bei schweren kindlichen Epilepsien stellt auch die ketogene Diät eine zu erwägende Option dar.


Sign in / Sign up

Export Citation Format

Share Document